Deep Track Capital, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001856083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2025 · 56 positions · Total reported value $3.58B · Top-10 concentration 52.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 59.3% · 18 new · 15 cut · 15 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +27.7% · vs SPY +12.9% · Prev Value $6.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2025 13F filing, Deep Track Capital, LP disclosed 56 equity positions with a combined reported value of $3.58B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were GH ($259.55M), IONS ($249.13M), CYTK ($236.33M). By sector, the heaviest allocations are Health Care 76.5%, Other 23.5%. Versus the prior quarter, allocation shifted toward Other (+1.9pp) and away from Health Care (-1.9pp).

Versus the prior quarter, Deep Track Capital, LP opened 18 new positions, trimmed 15 and fully exited 15, a turnover rate of 59.3% of positions. The portfolio's overlap with the prior quarter was 57% of names.

The largest new positions opened in Q3 2025 were EXAS ($54.71M), LBRX ($52.94M), QURE ($28.20M).

Of the 15 positions fully exited versus the prior quarter, the largest were INSM ($176.12M), RARE ($49.09M), DNTH ($41.60M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • EXAS EXACT SCIENCES CORP · $54.71M
  • LBRX LB PHARMACEUTICALS INC · $52.94M
  • QURE UNIQURE NV · $28.20M
  • DYN DYNE THERAPEUTICS INC · $25.30M
  • GMAB GENMAB A/S · $14.76M
  • TNGX TANGO THERAPEUTICS INC · $12.22M
  • IMA IMAGENEBIO INC · $7.16M
  • CRMD CORMEDIX INC · $5.82M

Fully Exited (vs previous quarter)

  • INSM INSMED INC · prev qtr: $176.12M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · prev qtr: $49.09M
  • DNTH DIANTHUS THERAPEUTICS INC COM · prev qtr: $41.60M
  • MTSR METSERA INC · prev qtr: $31.14M
  • TECX TECTONIC THERAPEUTIC · prev qtr: $27.86M
  • ABVX ABIVAX SA · prev qtr: $26.62M
  • UPB UPSTREAM BIO INC · prev qtr: $15.84M
  • MRUS MERUS N V · prev qtr: $14.46M

Insider Transactions (Form 4)

Latest Deep Track Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 1,957,138 — SEC filing

All insider transactions →

Fund Profile

Deep Track Capital, LP is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 66 US equity positions with a combined value of $6.72B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-120500 (status: Approved), registered 2021-03-12
  • Regulatory AUM (Form ADV): $8.37B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: deeptrackcapital.com

Portfolio Structure

  • 66 positions · $6.72B reported value (Q2 2026)
  • Top 10 holdings = 40.5% of reported value
  • Largest position: GH (GUARDANT HEALTH INC) at 7.6%
  • Average position size: $101.75M

Sector Tilt

  • Health Care 95.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 18 new, 20 added, 15 reduced, 15 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 76.5%
Other 23.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 4.15M $259.55M 7.24%
7.24%
Reduce
2 3.81M $249.13M 6.95%
6.95%
Reduce
3 4.30M $236.33M 6.59%
6.59%
Add
4 4.00M $189.97M 5.30%
5.30%
Add
5 8.00M $181.05M 5.05%
5.05%
Add
6 3.00M $178.29M 4.98%
4.98%
Add
7 9.73M $156.83M 4.38%
4.38%
Add
8 15.73M $156.16M 4.36%
4.36%
Reduce
9 11.93M $139.49M 3.89%
3.89%
Reduce
10 9.36M $137.54M 3.84%
3.84%
Reduce
11 4.22M $118.04M 3.29%
3.29%
Reduce
12 5.38M $116.11M 3.24%
3.24%
Hold
13 1.72M $113.97M 3.18%
3.18%
Reduce
14 900.00K $109.31M 3.05%
3.05%
Add
15 3.00M $108.06M 3.02%
3.02%
Add
16 3.95M $102.40M 2.86%
2.86%
Hold
17 1.80M $65.39M 1.82%
1.82%
Hold
18 1.20M $62.33M 1.74%
1.74%
Add
19 41.10M $56.30M 1.57%
1.57%
Reduce
20 7.50M $56.29M 1.57%
1.57%
Hold
21 6.06M $55.97M 1.56%
1.56%
Hold
22 3.15M $55.12M 1.54%
1.54%
Add
23 1.00M $54.71M 1.53%
1.53%
New
24 3.35M $52.94M 1.48%
1.48%
New
25 2.00M $51.74M 1.44%
1.44%
Hold
26 2.65M $51.05M 1.43%
1.43%
Add
27 1.20M $48.18M 1.34%
1.34%
Reduce
28 7.86M $45.04M 1.26%
1.26%
Reduce
29 450.00K $41.22M 1.15%
1.15%
Reduce
30 2.43M $38.32M 1.07%
1.07%
Hold
31 3.47M $33.97M 0.95%
0.95%
Add
32 300.00K $28.73M 0.80%
0.80%
Add
33 483.09K $28.20M 0.79%
0.79%
New
34 2.00M $25.30M 0.71%
0.71%
New
35 2.28M $19.68M 0.55%
0.55%
Reduce
36 751.42K $19.38M 0.54%
0.54%
Hold
37 1.25M $17.88M 0.50%
0.50%
Reduce
38 1.50M $17.68M 0.49%
0.49%
Reduce
39 2.24M $15.29M 0.43%
0.43%
Reduce
40 481.27K $14.76M 0.41%
0.41%
New
41 1.45M $12.22M 0.34%
0.34%
New
42 7.42M $7.19M 0.20%
0.20%
Hold
43 878.52K $7.16M 0.20%
0.20%
New
44 549.44K $6.44M 0.18%
0.18%
Hold
45 1.00M $5.89M 0.16%
0.16%
Reduce
46 500.00K $5.82M 0.16%
0.16%
New
47 1.20M $5.54M 0.15%
0.15%
New
48 453.69K $5.39M 0.15%
0.15%
Hold
49 444.11K $4.35M 0.12%
0.12%
Hold
50 2.57M $4.19M 0.12%
0.12%
Reduce

FAQ

What did Deep Track Capital, LP buy in 2025-Q3?

In its 2025-Q3 13F filing, Deep Track Capital, LP reported 56 equity positions worth $3.58B in aggregate; its largest disclosed positions were GH ($259.55M), IONS ($249.13M), CYTK ($236.33M).

How large is Deep Track Capital, LP's portfolio?

Deep Track Capital, LP reported $3.58B of long equity holdings across 56 positions as of 2025-Q3. Top-10 holdings account for 52.6% of reported value.

What is Deep Track Capital, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deep-track-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →